Bank of America Corp DE Acquires 14,863 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Bank of America Corp DE grew its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 27.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,474 shares of the medical instruments supplier's stock after buying an additional 14,863 shares during the period. Bank of America Corp DE owned 1.26% of Mesa Laboratories worth $9,030,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Amundi raised its stake in Mesa Laboratories by 81.6% in the fourth quarter. Amundi now owns 661 shares of the medical instruments supplier's stock worth $91,000 after buying an additional 297 shares in the last quarter. Resona Asset Management Co. Ltd. purchased a new position in shares of Mesa Laboratories during the 4th quarter worth approximately $92,000. KLP Kapitalforvaltning AS purchased a new position in shares of Mesa Laboratories during the 4th quarter worth approximately $132,000. Tower Research Capital LLC TRC raised its position in shares of Mesa Laboratories by 72.9% in the 4th quarter. Tower Research Capital LLC TRC now owns 1,328 shares of the medical instruments supplier's stock worth $175,000 after acquiring an additional 560 shares in the last quarter. Finally, Berry Wealth Group LP lifted its stake in shares of Mesa Laboratories by 5.3% in the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock valued at $219,000 after purchasing an additional 83 shares during the period. 90.60% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the transaction, the chief executive officer now owns 43,337 shares of the company's stock, valued at approximately $5,369,887.67. This trade represents a 32.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 4.40% of the company's stock.

Mesa Laboratories Stock Up 3.0%

Shares of NASDAQ MLAB traded up $3.35 during mid-day trading on Tuesday, hitting $113.20. 34,879 shares of the stock traded hands, compared to its average volume of 40,002. The company has a market cap of $615.13 million, a price-to-earnings ratio of -2.45 and a beta of 0.97. The stock has a fifty day moving average price of $116.84 and a 200-day moving average price of $126.46. Mesa Laboratories, Inc. has a 52 week low of $83.68 and a 52 week high of $155.12. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.53 and a current ratio of 0.71.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 30th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.57%. The ex-dividend date is Friday, May 30th. Mesa Laboratories's dividend payout ratio is currently -1.38%.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.